Last 7 days
-1.5%
Last 30 days
5.3%
Last 90 days
35.5%
Trailing 12 Months
30.4%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-07 | Kalif Eliyahu Sharon | sold | -341,889 | 9.7335 | -35,125 | evp, chief financial officer |
2023-08-04 | Zaks Tal Zvi | acquired | - | - | 15,810 | - |
2023-08-04 | BARER SOL J | acquired | - | - | 28,162 | - |
2023-08-04 | Crane Rosemary A | acquired | - | - | 15,810 | - |
2023-08-04 | Satchi-Fainaro Ronit | acquired | - | - | 15,810 | - |
2023-08-04 | Vergis Janet S. | acquired | - | - | 15,810 | - |
2023-08-04 | LIEBERMAN GERALD M | acquired | - | - | 15,810 | - |
2023-08-04 | Elstein Amir | acquired | - | - | 15,810 | - |
2023-08-04 | Nisen Perry | acquired | - | - | 15,810 | - |
2023-08-04 | Weiss Amir | sold | -19,657 | 9.921 | -1,981 | chief accounting officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-26 | BROOKFIELD Corp /ON/ | reduced | -72.04 | -2,948,150 | 920,219 | -% |
2023-09-21 | Baystate Wealth Management LLC | unchanged | - | -528 | 3,012 | -% |
2023-09-21 | Jefferies Group LLC | reduced | -6.16 | 14,688 | 2,087,420 | 0.02% |
2023-09-20 | BARCLAYS PLC | reduced | -41.25 | -7,900,000 | 7,898,000 | -% |
2023-09-12 | Farther Finance Advisors, LLC | added | 80.00 | 917 | 2,643 | -% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 279 | 279 | -% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | -157,212 | 896,823 | 0.01% |
2023-08-23 | WOLVERINE TRADING, LLC | added | 21.94 | 63,907 | 1,446,910 | -% |
2023-08-23 | Stonebridge Capital Advisors LLC | unchanged | - | -132 | 753 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -0.16 | -1,560,640 | 8,806,170 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jun 09, 2023 | capital research global investors | 0.0% | 0 | SC 13G/A | |
Feb 13, 2023 | capital research global investors | 10.3% | 114,793,989 | SC 13G/A | |
Feb 11, 2022 | capital research global investors | 12.0% | 132,350,750 | SC 13G/A | |
Feb 16, 2021 | capital research global investors | 11.9% | 130,140,247 | SC 13G/A | |
Feb 03, 2021 | wellington management group llp | 0.03% | 310,793 | SC 13G/A | |
Feb 14, 2020 | capital research global investors | 11.9% | 130,950,677 | SC 13G/A | |
Feb 05, 2020 | franklin resources inc | 1.8% | 19,916,016 | SC 13G/A | |
Jan 28, 2020 | wellington management group llp | 7.43% | 81,123,996 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 28, 2023 | 8-K | Current Report | |
Sep 05, 2023 | 3 | Insider Trading | |
Sep 05, 2023 | 4 | Insider Trading | |
Aug 24, 2023 | 8-K | Current Report | |
Aug 10, 2023 | 3 | Insider Trading | |
Aug 10, 2023 | 4 | Insider Trading | |
Aug 09, 2023 | 4 | Insider Trading | |
Aug 07, 2023 | 4 | Insider Trading | |
Aug 07, 2023 | 4 | Insider Trading | |
Aug 07, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
LLY | 483.3B | 29.5B | -1.98% | 63.22% | 74.38 | 16.37 | 1.53% | 14.16% |
JNJ | 404.7B | 97.8B | -4.87% | -4.04% | 31 | 4.14 | 2.29% | -28.92% |
MRK | 272.8B | 58.3B | -6.59% | 20.44% | 17.88 | 4.63 | 2.00% | -81.24% |
PFE | 187.3B | 77.9B | -7.60% | -24.24% | 8.72 | 2.4 | -23.04% | -26.74% |
BMY | 150.1B | 45.2B | -6.96% | -18.45% | 23.72 | 3.25 | -4.15% | 20.34% |
MID-CAP | ||||||||
RETA | 6.5B | - | 1.99% | 679.20% | -74.1 | 4.1K | -86.94% | 71.24% |
PRGO | 4.3B | 4.6B | -10.37% | -11.13% | -63.85 | 0.93 | 6.60% | 42.04% |
SMALL-CAP | ||||||||
TLRY | 1.6B | 627.1M | -7.75% | -16.43% | -1.08 | 2.5 | -0.20% | -204.67% |
SUPN | 1.5B | 634.0M | -13.76% | -17.16% | 34.51 | 2.36 | 0.62% | -24.59% |
INVA | 847.3M | 244.3M | 0.39% | 9.53% | 4.3 | 3.47 | -39.50% | -4.99% |
CRON | 762.2M | 109.5M | 6.95% | -31.74% | -5.31 | 6.96 | -2.66% | -32.13% |
ACRS | 484.8M | 31.2M | -8.67% | -53.78% | -4.6 | 15.55 | 407.54% | -26.47% |
CGC | 430.9M | 453.3M | 72.08% | -71.84% | -0.35 | 0.95 | -16.04% | 55.90% |
OCUL | 248.8M | 54.6M | -18.44% | -38.79% | -2.74 | 4.56 | 9.39% | -179.16% |
ENDP | - | 2.2B | - | - | - | - | -22.39% | 63.59% |
-11.2%
-18.9%
-13.9%
4.9%
100%
91.2%
37.7%
Y-axis is the maximum loss one would have experienced if Teva Pharmaceutical Industries was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 0.6% | 15,018,000,000 | 14,926,000,000 | 14,925,000,000 | 15,142,000,000 | 15,434,000,000 | 15,558,000,000 | 15,878,000,000 | 16,233,000,000 | 16,324,000,000 | 16,284,000,000 | 16,659,000,000 | 16,673,000,000 | 16,788,000,000 | 17,095,000,000 | 16,887,000,000 | 16,838,000,000 | 17,130,000,000 | 17,505,000,000 | 18,272,000,000 | 19,251,000,000 | 20,483,000,000 |
Gross Profit | 0.0% | 6,817,000,000 | 6,815,000,000 | 6,973,000,000 | 7,253,000,000 | 7,378,000,000 | 7,457,000,000 | 7,594,000,000 | 7,593,000,000 | 7,651,000,000 | 7,541,000,000 | 7,726,000,000 | 7,636,000,000 | 7,614,000,000 | 7,744,000,000 | 7,537,000,000 | 7,550,000,000 | 7,697,000,000 | 7,837,000,000 | 8,296,000,000 | 8,769,000,000 | 9,391,000,000 |
S&GA Expenses | 0.4% | 2,237,000,000 | 2,228,000,000 | 2,265,000,000 | 2,348,000,000 | 2,406,000,000 | 2,427,000,000 | 2,429,000,000 | 2,480,000,000 | 2,488,000,000 | 2,470,000,000 | 2,498,000,000 | 2,521,000,000 | 2,511,000,000 | 2,580,000,000 | 2,614,000,000 | 2,706,000,000 | 2,810,000,000 | 2,826,000,000 | 2,916,000,000 | 2,769,000,000 | 2,913,000,000 |
R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 114,000,000 | 54,000,000 | 229,000,000 |
EBITDA | 100.0% | - | -116,000,000 | -809,000,000 | - | -594,000,000 | 1,712,000,000 | 2,879,000,000 | - | - | -1,794,000,000 | -1,948,000,000 | -2,182,000,000 | 2,017,000,000 | 1,286,000,000 | 1,279,000,000 | -2,005,000,000 | -1,865,000,000 | -1,236,000,000 | 166,000,000 | -9,554,000,000 | -9,169,000,000 |
EBITDA Margin | 100.0% | - | -0.01 | -0.05 | - | -0.04 | 0.11 | 0.18 | - | - | -0.11 | -0.12 | -0.13 | 0.12 | 0.07 | 0.07 | -0.12 | -0.11 | -0.07 | 0.01 | -0.49 | -0.44 |
Interest Expenses | - | - | - | 948,000,000 | - | - | - | 913,000,000 | - | - | - | 846,000,000 | - | - | - | 840,000,000 | - | - | - | 815,000,000 | - | - |
Earnings Before Taxes | 10.5% | -2,107,000,000 | -2,353,000,000 | -3,065,000,000 | -2,140,000,000 | -1,924,000,000 | -456,000,000 | 658,000,000 | 971,000,000 | -3,870,000,000 | -4,229,000,000 | -4,406,000,000 | -4,582,000,000 | -415,000,000 | -1,214,000,000 | -1,265,000,000 | -4,613,000,000 | -4,534,000,000 | -3,934,000,000 | -2,596,000,000 | -12,417,000,000 | -12,085,000,000 |
EBT Margin | 100.0% | - | -0.16 | -0.21 | -0.14 | -0.12 | -0.03 | 0.04 | 0.06 | -0.24 | -0.26 | -0.26 | -0.27 | -0.02 | -0.07 | -0.07 | -0.27 | -0.26 | -0.22 | -0.14 | -0.63 | -0.58 |
Net Income | -39.4% | -2,233,000,000 | -1,602,000,000 | -2,353,000,000 | -1,290,000,000 | -1,054,000,000 | -615,000,000 | 417,000,000 | 726,000,000 | -3,915,000,000 | -3,982,000,000 | -3,990,000,000 | -4,030,000,000 | 5,000,000 | -824,000,000 | -998,000,000 | -3,994,000,000 | -3,888,000,000 | -3,375,000,000 | -2,150,000,000 | -10,799,000,000 | -9,996,000,000 |
Net Income Margin | 100.0% | - | -0.11 | -0.16 | -0.09 | -0.07 | -0.04 | 0.03 | 0.04 | -0.24 | -0.24 | -0.24 | -0.24 | 0.00 | -0.05 | -0.06 | -0.23 | -0.22 | -0.19 | -0.11 | -0.55 | -0.48 |
Free Cashflow | -100.0% | - | 964,000,000 | 1,042,000,000 | 514,000,000 | 476,000,000 | 585,000,000 | 236,000,000 | 88,000,000 | -131,000,000 | -94,000,000 | 638,000,000 | 902,000,000 | 894,000,000 | 413,000,000 | 223,000,000 | -42,000,000 | 84,000,000 | 449,000,000 | 1,795,000,000 | 2,233,000,000 | 2,534,000,000 |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -0.8% | 43,095 | 43,456 | 44,006 | 44,252 | 45,932 | 47,059 | 47,666 | 47,851 | 49,195 | 49,004 | 50,640 | 49,737 | 54,991 | 55,330 | 57,470 | 57,246 | 59,424 | 59,854 | 60,683 | 65,061 | 67,030 |
Current Assets | 5.1% | 12,088 | 11,501 | 12,051 | 11,453 | 12,164 | 12,451 | 12,573 | 12,154 | 12,822 | 12,401 | 13,005 | 12,160 | 12,781 | 12,884 | 13,464 | 12,542 | 13,805 | 13,431 | 13,794 | 13,881 | 14,711 |
Cash Equivalents | 22.7% | 2,669 | 2,176 | 2,801 | 2,225 | 2,058 | 2,250 | 2,198 | 2,045 | 2,436 | 1,743 | 2,177 | 1,827 | 2,402 | 1,804 | 1,975 | 1,241 | 2,165 | 1,973 | 1,782 | 1,875 | 1,861 |
Inventory | -0.2% | 4,109 | 4,118 | 3,833 | 3,859 | 4,049 | 4,012 | 3,818 | 4,167 | 4,362 | 4,406 | 4,403 | 4,516 | 4,361 | 4,290 | 4,422 | 4,636 | 4,850 | 4,782 | 4,731 | 4,866 | 4,971 |
Net PPE | -0.7% | 5,712 | 5,751 | 5,739 | 5,568 | 5,740 | 5,932 | 5,982 | 6,040 | 6,127 | 6,112 | 6,296 | 6,152 | 6,122 | 6,221 | 6,436 | 6,643 | 6,732 | 6,785 | 6,868 | 7,101 | 7,213 |
Goodwill | -3.8% | 17,118 | 17,799 | 17,633 | 18,433 | 18,837 | 19,986 | 20,040 | 20,179 | 20,421 | 20,302 | 20,624 | 20,228 | 24,616 | 24,490 | 24,846 | 24,657 | 24,913 | 24,822 | 24,917 | 27,585 | 27,648 |
Liabilities | 1.6% | 35,387 | 34,844 | 35,315 | 34,734 | 36,103 | 36,799 | 36,422 | 36,400 | 37,884 | 38,029 | 39,579 | 39,145 | 40,167 | 40,742 | 42,407 | 42,322 | 44,173 | 44,033 | 44,889 | 45,927 | 47,662 |
Current Liabilities | 13.8% | 11,843 | 10,411 | 11,469 | 11,534 | 10,996 | 11,613 | 11,027 | 11,825 | 12,691 | 12,089 | 13,164 | 12,103 | 11,751 | 12,322 | 13,674 | 14,107 | 14,452 | 14,028 | 14,322 | 14,830 | 14,215 |
Shareholder's Equity | -18.1% | 7,052 | 8,612 | 7,897 | 8,767 | 9,828 | 10,260 | 11,244 | 11,451 | 11,311 | 10,975 | 11,061 | 10,592 | 14,824 | 14,588 | 15,063 | 14,925 | 15,251 | 15,821 | 15,794 | 19,134 | 19,368 |
Retained Earnings | -6.6% | -13,950 | -13,086 | -12,882 | -11,660 | -11,716 | -11,484 | -10,529 | -10,370 | -10,662 | -10,869 | -10,946 | -11,096 | -6,747 | -6,887 | -6,956 | -7,066 | -6,752 | -6,063 | -5,958 | -3,072 | -2,864 |
Additional Paid-In Capital | 0.1% | 27,748 | 27,719 | 27,688 | 27,652 | 27,625 | 27,587 | 27,561 | 27,529 | 27,503 | 27,474 | 27,443 | 27,403 | 27,374 | 27,342 | 27,312 | 27,293 | 27,258 | 27,234 | 27,210 | 23,404 | 23,426 |
Shares Outstanding | 0.4% | 1,120 | 1,115 | - | 1,111 | 1,110 | 1,107 | - | 1,103 | 1,103 | 1,099 | - | 1,096 | 1,096 | 1,093 | - | 1,092 | 1,092 | 1,090 | - | 1,018 | 1,018 |
Minority Interest | -12.6% | 656 | 751 | 794 | 751 | 791 | 916 | 966 | 984 | 987 | 975 | 1,035 | 999 | 972 | 1,057 | 1,091 | 1,134 | 1,128 | 1,089 | 1,087 | 1,404 | 1,430 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 13.5% | 1,695 | 1,494 | 1,590 | 1,073 | 1,059 | 1,154 | 798 | 673 | 451 | 506 | 1,216 | 1,423 | 1,441 | 941 | 748 | 577 | 673 | 1,062 | 2,446 | 2,938 | 3,312 |
Share Based Compensation | -6.8% | 123 | 132 | 124 | 121 | 122 | 112 | 119 | 124 | 127 | 130 | 129 | 111 | 117 | 115 | 119 | 132 | 142 | 159 | 155 | 149 | 135 |
Cashflow From Investing | 18.2% | 798 | 675 | 656 | 733 | 874 | 1,176 | 1,523 | 1,418 | 1,287 | 1,119 | 863 | 1,152 | 1,219 | 1,335 | 1,355 | 999 | 1,122 | 1,099 | 1,866 | 3,704 | 3,461 |
Cashflow From Financing | 12.9% | -1,912 | -2,195 | -1,487 | -1,277 | -2,014 | -1,677 | -2,172 | -1,796 | -1,676 | -1,678 | -1,885 | -2,001 | -2,405 | -2,437 | -1,926 | -2,184 | -1,428 | -1,449 | -3,351 | -5,358 | -5,478 |
Dividend Payments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.00 | 99.00 | 222 |
Consolidated Statements of Income (Loss) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Net revenues | $ 3,878 | $ 3,786 | $ 7,539 | $ 7,447 |
Cost of sales | 2,082 | 1,992 | 4,161 | 3,913 |
Gross profit | 1,796 | 1,794 | 3,378 | 3,534 |
Research and development expenses | 240 | 228 | 473 | 453 |
Selling and marketing expenses | 603 | 594 | 1,149 | 1,178 |
General and administrative expenses | 307 | 313 | 602 | 609 |
Intangible assets impairments | 63 | 51 | 241 | 199 |
Goodwill impairment | 700 | 745 | 700 | 745 |
Other assets impairments, restructuring and other items | 100 | 118 | 195 | 246 |
Legal settlements and loss contingencies | 462 | 729 | 695 | 1,854 |
Other income | (33) | (34) | (34) | (87) |
Operating income (loss) | (646) | (949) | (644) | (1,662) |
Financial expenses, net | 268 | 211 | 528 | 468 |
Income (loss) before income taxes | (914) | (1,160) | (1,172) | (2,131) |
Income taxes (benefit) | (16) | (900) | (35) | (899) |
Share in (profits) losses of associated companies, net | (1) | 0 | (1) | (21) |
Net income (loss) | (898) | (259) | (1,136) | (1,211) |
Net income (loss) attributable to non-controlling interests | (35) | (27) | (68) | (24) |
Net income (loss) attributable to Teva | $ (863) | $ (232) | $ (1,068) | $ (1,187) |
Earnings (loss) per share attributable to ordinary shareholders: | ||||
Basic | $ (0.77) | $ (0.21) | $ (0.96) | $ (1.07) |
Diluted | $ (0.77) | $ (0.21) | $ (0.96) | $ (1.07) |
Weighted average number of shares (in millions): | ||||
Basic | 1,120 | 1,110 | 1,118 | 1,109 |
Diluted | 1,120 | 1,110 | 1,118 | 1,109 |
Consolidated Balance Sheets - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 | ||
---|---|---|---|---|
Current assets: | ||||
Cash and cash equivalents | $ 2,669 | $ 2,801 | ||
Accounts receivables, net of allowance for credit losses of $87 million and $91 million as of June 30, 2023 and December 31, 2022 | 3,539 | 3,696 | ||
Inventories | 4,109 | 3,833 | ||
Prepaid expenses | 1,228 | 1,162 | ||
Other current assets | 486 | 549 | ||
Assets held for sale | 56 | 10 | ||
Total current assets | 12,088 | 12,051 | ||
Deferred income taxes | 1,578 | 1,453 | ||
Other non-current assets | 443 | 441 | ||
Property, plant and equipment, net | 5,712 | 5,739 | ||
Operating lease right-of-use assets, net | 418 | 419 | ||
Identifiable intangible assets, net | 5,738 | 6,270 | ||
Goodwill | [1] | 17,118 | 17,633 | |
Total assets | 43,095 | 44,006 | ||
Current liabilities: | ||||
Short-term debt | 1,980 | 2,109 | ||
Sales reserves and allowances | 3,433 | 3,750 | ||
Accounts payables | 2,508 | 1,887 | ||
Employee-related obligations | 451 | 566 | ||
Accrued expenses | 2,498 | 2,151 | ||
Other current liabilities | 973 | 1,005 | ||
Total current liabilities | 11,843 | 11,469 | ||
Long-term liabilities: | ||||
Deferred income taxes | 534 | 548 | ||
Other taxes and long-term liabilities | 3,973 | 3,847 | ||
Senior notes and loans | 18,698 | 19,103 | ||
Operating lease liabilities | 338 | 349 | ||
Total long-term liabilities | 23,543 | 23,846 | ||
Commitments and contingencies, see note 10 | ||||
Total liabilities | 35,387 | 35,315 | ||
Teva shareholders' equity: | ||||
Ordinary shares of NIS 0.10 par value per share; June 30, 2023 and December 31, 2022: authorized 2,495 million shares; issued 1,227 million shares and 1,217 million shares, respectively. | 57 | 57 | ||
Additional paid-in capital | 27,748 | 27,688 | ||
Accumulated deficit | (13,950) | (12,882) | ||
Accumulated other comprehensive loss | (2,677) | (2,838) | ||
Treasury shares as of June 30, 2023 and December 31, 2022: 106 million ordinary shares | (4,128) | (4,128) | ||
Stockholders' equity attributable to Teva shareholders | 7,052 | 7,897 | ||
Non-controlling interests | 656 | 794 | ||
Total equity | 7,708 | 8,691 | ||
Total liabilities and equity | $ 43,095 | $ 44,006 | ||
|